Browsing by Yonsei Author : Kim, Hye Ryun

eperson profile image
Name:
Kim, Hye Ryun [김혜련]
orcid http://orcid.org/0000-0002-1842-9070
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (8583782700)

Keyword Cloud

Researcher Network

Showing results 101 to 150 of 206

This table browses all dspace content
Issue DateTitleJournal Title
2019Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancerAnnals of Oncology
2019Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitorsCancer Chemotherapy and Pharmacology
2019A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIsLung Cancer
2019Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma Cancer Research and Treatment
2019A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13 CANCER RESEARCH AND TREATMENT
2019Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2019YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung CancerCLINICAL CANCER RESEARCH
2019TRIUMPH Trial: One Small Step Could Become One Giant Leap for Precision Oncology in Head and Neck Cancer CANCER RESEARCH AND TREATMENT
2019Indoor radon exposure increases tumor mutation burden in never-smoker patients with lung adenocarcinomaLUNG CANCER
2019Real-World Analysis of the Efficacy of Rebiopsy and EGFR Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer YONSEI MEDICAL JOURNAL
2019Neoadjuvant therapy for thymic neoplasms reduces tumor volume per 3D-reconstructed images but does not improve the complete resection rate PLOS ONE
2019The Ratio of Peripheral Regulatory T Cells to Lox-1+ Polymorphonuclear Myeloid-derived Suppressor Cells Predicts the Early Response to Anti-PD-1 Therapy in Patients with Non-Small Cell Lung CancerAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
2018Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung CancerNew England Journal of Medicine
2018ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinomaONCOGENE
2018Survival and Functional Outcome after Treatment for Primary Base of Tongue Cancer: A Comparison of Definitive Chemoradiotherapy versus Surgery Followed by Adjuvant Radiotherapy. CANCER RESEARCH AND TREATMENT
2018Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical PracticeJOURNAL OF THORACIC ONCOLOGY
2018Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors.CANCER RESEARCH
2018Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotationLUNG CANCER
2018Radon Exposure-induced Genetic Variations in Lung Cancers among Never Smokers JOURNAL OF KOREAN MEDICAL SCIENCE
2018Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer Endocrinology and Metabolism (대한내분비학회지)
2018A Clinical Trial of Combination Neoadjuvant Chemotherapy and Transoral Robotic Surgery in Patients with T3 and T4 Laryngo-Hypopharyngeal CancerANNALS OF SURGICAL ONCOLOGY
2018The Benefit of Pro Re Nata Antiemetics Provided With Guideline-Consistent Antiemetics in Delayed Nausea ControlCANCER NURSING
2018Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and/or metastatic salivary gland cancer of the head and neckHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
2017Novel Genetic Associations Between Lung Cancer and Indoor Radon Exposure JOURNAL OF CANCER PREVENTION
2017Patient Experience of Symptoms and Side Effects when Treated with Osimertinib for Advanced Non-Small-Cell Lung Cancer: A Qualitative Interview SubstudyPATIENT-PATIENT CENTERED OUTCOMES RESEARCH
2017Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion studyLANCET RESPIRATORY MEDICINE
2017Concordance of programmed death-ligand 1 expression between primary and metastatic non-small cell lung cancer by immunohistochemistry and RNA in situ hybridization ONCOTARGET
2017Transoral robotic surgery-based therapy in patients with stage III-IV oropharyngeal squamous cell carcinomaORAL ONCOLOGY
2017Architectural patterns of p16 immunohistochemical expression associated with cancer immunity and prognosis of head and neck squamous cell carcinomaAPMIS
2017Next-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIsLUNG CANCER
2017A randomized; phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) (vol 8; pg 15943; 2017) ONCOTARGET
2017Validation of ALK/ROS1 Dual Break Apart FISH Probe probe in non-small-cell lung cancerLUNG CANCER
2017Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer NEW ENGLAND JOURNAL OF MEDICINE
2017Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01)CANCER
2017Significance of immune checkpoint proteins in EGFR-mutant non-small cell lung cancerLUNG CANCER
2017Predictive factors of early distant brain failure after gamma knife radiosurgery alone in patients with brain metastases of non-small-cell lung cancerJOURNAL OF NEURO-ONCOLOGY
2017Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinomaANNALS OF ONCOLOGY
2017Optimal dose and volume for postoperative radiotherapy in brain oligometastases from lung cancer: a retrospective study RADIATION ONCOLOGY JOURNAL
2017Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement.JOURNAL OF CLINICAL ONCOLOGY
2017Detection of activating and acquired resistant mutation in plasma from EGFR-mutated NSCLC patients by peptide nucleic acid (PNA) clamping-assisted fluorescence melting curve analysis ONCOTARGET
2017Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Positive Human Non-Small Cell Lung CancerJOURNAL OF THORACIC ONCOLOGY
2017Prevalence and prognostic implications of psychological distress in patients with gastric cancer BMC CANCER
2016Clinical course of stage IV invasive mucinous adenocarcinoma of the lungLUNG CANCER
2016PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients SCIENTIFIC REPORTS
2016Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants JOURNAL OF TRANSLATIONAL MEDICINE
2016Alteration status and prognostic value of MET in head and neck squamous cell carcinoma JOURNAL OF CANCER
2016Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution PLOS ONE
2016Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinomaHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
2016Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02) ONCOTARGET
2016Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus ONCOTARGET

Browse

Links